Novo Nordisk cuts Ozempic and Wegovy prices to $499/month for the uninsured, aiming to reduce reliance on unsafe compounded ...

Glaucoma, a leading cause of preventable blindness in the UK, often progresses silently, damaging the optic nerve and causing irreversible vision loss ...

Glaucoma is one of the most common causes of irreversible vision loss, especially in older adults. It slowly damages the ...

Avoiding and managing ocular radiotoxicity are increasingly important as more patients undergo radiotherapy for HNC, ...

Patients with type 2 diabetes (T2D) on semaglutide or tirzepatide showed a higher incidence of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders compared to other ...

This U.S. patent allowance secures long-term protection for our proprietary manufacturing process,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “With patent coverage in place and the ...

DelveInsight's Open-Angle Glaucoma Market Insights report includes a comprehensive understanding of current treatment ...

Dr. Lior Shaltiel, CEO, will speak at the Bioprocess International Conference in Boston, MA, one of the largest global gatherings for biomanufacturing innovation. His presentation is entitled “From ...

Age-related macular degeneration affects your central vision but leaves your peripheral vision unchanged. It's a leading cause of vision problems, including vision loss, in people over 50, per the ...

Glaukos posts 30% revenue growth and pipeline expansion but faces regulatory and valuation risks. Read more on why I ...

Tooth-in-eye surgery sounds like science fiction, but it can help people with severely damaged corneas see again. A patient ...

Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG ...